Valerio Therapeutics (FR0010095596 – ALVIO), a biotechnology company specializing in the development of technology platforms dedicated to the targeted delivery of innovative therapies (the “Company”), ...

Integrant today announced the formal publication of its proprietary “CTC Formula” in Chaos to Creation, (ISBN9798255688227) marking the first time the framework has been made accessible to the public, ...

Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D ...

Two River, LLC (“Two River”) and Vida Ventures (“Vida”), both part of the Bellco Health ecosystem, today acknowledged the announced acquisition of Candid Therapeutics (“Candid”), a privately held ...

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics ...

Matthew C. Zorn previously argued that federal regulators determine "accepted medical use" through the FDA approval framework. Today, he appears on behalf of the United States defending a CMS program ...

The first consumer experiences powered by true molecular medicine infrastructure are now live at lite.dendrite.com. Take a quiz built from your own genome. Read the seven-chapter story of your biology ...

Oral argument heard Friday, May 1, 2026 in Smart Approaches to Marijuana v. Kennedy — with Ilya Shapiro arguing for ...

Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per monthBrief Summary:GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per ...

Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical TechnologyLOS ANGELES & ATLANTA--(BUSINESS ...

TaeWoong Medical USA today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Niti-S SPAXUS™ Stent, further strengthening its portfolio of endoscopic ultrasound ...

UCB acquires IMIDomics’ Patient Insight Business, gaining access to one of the world’s most comprehensive multi omic datasets for immune mediated inflammatory diseasesPatient Insight Business enhances ...